| 000 | 01646 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515045448.0 | ||
| 264 | 0 | _c20070301 | |
| 008 | 200703s 0 0 eng d | ||
| 022 | _a0785-3890 | ||
| 024 | 7 |
_a10.1080/07853890600969213 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMöllsten, Anna | |
| 245 | 0 | 0 |
_aGlu298Asp and NOS4ab polymorphisms in diabetic nephropathy. _h[electronic resource] |
| 260 |
_bAnnals of medicine _c2006 |
||
| 300 |
_a522-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAlbuminuria _xgenetics |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xcomplications |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFinland |
| 650 | 0 | 4 | _aGenetic Markers |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type III _xgenetics |
| 650 | 0 | 4 |
_aPolymorphism, Genetic _xgenetics |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSmoking _xadverse effects |
| 650 | 0 | 4 | _aStatistics as Topic |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 | _aSweden |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aWessman, Maija | |
| 700 | 1 | _aSvensson, Maria | |
| 700 | 1 | _aForsblom, Carol | |
| 700 | 1 | _aParkkonen, Maikki | |
| 700 | 1 | _aBrismar, Kerstin | |
| 700 | 1 | _aGroop, Per-Henrik | |
| 700 | 1 | _aDahlquist, Gisela | |
| 773 | 0 |
_tAnnals of medicine _gvol. 38 _gno. 7 _gp. 522-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/07853890600969213 _zAvailable from publisher's website |
| 999 |
_c16673965 _d16673965 |
||